Tobin W. Juvenal - 03 Mar 2026 Form 4 Insider Report for CASTLE BIOSCIENCES INC (CSTL)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Mar 2026, 17:18:41 UTC
Prior SEC filing
14 Jan 2026
Next SEC filing
16 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Frank Stokes, Attorney-in-fact

Key filing fact

Tobin W. Juvenal filed Form 4 for CASTLE BIOSCIENCES INC (CSTL) on 05 Mar 2026.

Key facts

  • This page summarizes Tobin W. Juvenal's Form 4 filing for CASTLE BIOSCIENCES INC (CSTL).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 05 Mar 2026, 17:18.

Change

  • Previous filing in this sequence was filed on 14 Jan 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001856542 Primary reporting owner

Juvenal Tobin W

Relationship
Chief Commercial Officer
Address
C/O CASTLE BIOSCIENCES, INC., 1500 W. PARKWOOD AVE SUITE 400, FRIENDSWOOD
Signature
/s/ Frank Stokes, Attorney-in-fact
Signature date
05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CSTL transaction

Common Stock

Tax liability

Transaction value
Shares
-3,716
Change %
-3.9%
Price
$27.57*
Shares after
92,316
Date
03 Mar 2026
Ownership
Direct
Footnotes
F1
CSTL transaction

Common Stock

Options Exercise

Transaction value
Shares
+25,771
Change %
+28%
Price
Shares after
118,087
Date
04 Mar 2026
Ownership
Direct
Footnotes
F2
CSTL transaction

Common Stock

Tax liability

Transaction value
Shares
-10,399
Change %
-8.8%
Price
$28.17*
Shares after
107,688
Date
04 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CSTL transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares
+48,367
Change %
Price
$0.000000*
Shares after
48,367
Date
03 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
48,367
Exercise price
Footnotes
F2, F3
CSTL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-13,811
Change %
-33%
Price
$0.000000*
Shares after
27,621
Date
04 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
13,811
Exercise price
Footnotes
F2, F4
CSTL transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-11,960
Change %
-25%
Price
$0.000000*
Shares after
35,878
Date
04 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,960
Exercise price
Footnotes
F2, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the delivery of vested performance stock units reported on January 12, 2026.

Footnote F2

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Footnote F3

The RSU's vest in four equal annual installments beginning on March 03, 2027.

Footnote F4

On March 4, 2024, the Reporting Person was granted 55,243 RSUs which vest in four equal installments beginning on March 4, 2025.

Footnote F5

On March 4, 2025, the Reporting Person was granted 47,838 RSUs which vest in four equal installments beginning on March 4, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .